Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

January 5, 2024

https://www.globenewswire.com/news-release/2024/01/05/2804595/0/en/Prime-Medicine-Appoints-Allan-Reine-M-D-as-Chief-Financial-Officer.html

CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Allan Reine, M.D., as the Company’s Chief Financial Officer, effective January 17, 2024. A seasoned financial executive with over twenty years’ experience in the biotechnology industry, Dr. Reine will be responsible for the company’s financing strategy and investor relations, and will oversee all financial operations as Prime Medicine begins its transition into a clinical company.

Read more at globenewswire.com

Related news for (PRME)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.